Researchers at the University of California, San Francisco (UCSF) and the Gladstone Institutes have uncovered a potential new approach to treating Alzheimer’s disease using two existing FDA-approved cancer drugs. The drugs, letrozole and irinotecan, have been found to reduce tau protein clumps in mice, a key feature of Alzheimer’s, and improve cognitive functions like memory and learning. Repurposing Cancer Drugs …
Read More »Alzheimer’s Could Be Treated with These Two FDA-Approved Cancer Drugs, New Research Finds
